10:52 AM EDT, 10/07/2025 (MT Newswires) -- Zimmer Biomet ( ZBH ) said Tuesday it has completed the acquisition of Monogram Technologies ( MGRM ) , bolstering its portfolio of orthopedic robotics and navigation technologies.

Under the agreement, Monogram shareholders received $4.04 in cash per share and non-tradeable contingent value rights that could provide up to $12.37 per share if certain milestones are achieved through 2030, according to a statement.

Monogram's semi-autonomous total knee arthroplasty robotic technology, which secured FDA 510(k) clearance in March, is expected to be commercialized with Zimmer Biomet ( ZBH ) implants by early 2027, according to the company.

Price: 99.03, Change: +0.20, Percent Change: +0.20